1-2 of 2
Zachary Knight
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Free
Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser, Sanchita Bhattacharya, Doris Siwak, Rina Gendelman, Nora Bayani, Nicholas J. Wang, Richard M. Neve, Yinghui Guan, Zhi Hu, Zachary Knight, Heidi S. Feiler, Philippe Gascard, Bahram Parvin, Paul T. Spellman, Kevan M. Shokat, Andrew J. Wyrobek, Mina J. Bissell, Frank McCormick, Wen-Lin Kuo, Gordon B. Mills, Joe W. Gray, W. Michael Korn
Journal: Cancer Research
Cancer Res (2009) 69 (2): 565–572.
https://doi.org/10.1158/0008-5472.CAN-08-3389
Published: 15 January 2009
View article titled, Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
Open the PDF for Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

In vivo destabilization of MYCN by PI3K p110 alpha inhibition

Free
Matthew Grimmer, Louis Chesler, Zachary Knight, Eli Zunder, Benjamin Houseman, Rodney Collins, Kim Nguyen, Slava Yakovenko, Selma Masic, Tarik Tihan, Kevan Shokat, William Weiss
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4979.
Published: 01 May 2008
View article titled, In vivo destabilization of MYCN by PI3K p110 alpha inhibition